{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-22-000005","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2022-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.091458+00:00","generated_at":"2026-06-27T18:30:47.742549+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quest Diagnostics Q4 rev $2.74B (-9% YoY); FY EPS beats outlook; 2022 guidance raised","bullets":["Preliminary Q4 2021 revenue ~$2.74B, down 9% from $3.00B in Q4 2020.","Q4 reported diluted EPS $3.12; adjusted diluted EPS $3.33 (vs $4.48 adjusted in Q4 2020).","Full year 2021 revenue ~$10.79B (+14% YoY); adjusted diluted EPS $14.24 exceeded prior outlook.","COVID-19 testing demand higher than expected; Q4 included 7.9M molecular tests and 0.7M serology tests.","2022 guidance raised: now expects adjusted diluted EPS above $8.00 (prior was near upper end of $7.40-$8.00)."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-22-000005","json":"https://secwatch.observer/filing/0001022079-22-000005.json","markdown":"https://secwatch.observer/filing/0001022079-22-000005.md","text":"https://secwatch.observer/filing/0001022079-22-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000005/0001022079-22-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000005/dgx-20220112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:30:47.742549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}